Net sales of proprietary products increase year over year. Shares rise. Alkermes ( NASDAQ:ALKS ) Full Year 2024 Results Key Financial Results Revenue: US$1.56b (down 6.4% from FY 2023).

What is the accepted ceremony: genuflect in front of a statue? Timothy Cardinal Dolan, whom the public loves, had 100 of his friends at the NY Athletic Club. Drinks, a few words, chicken barbecue ...

Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Alkermes (ALKS – Research Report) today and set a price target of $36.00. The company’s shares closed last Friday at $31.57.

Alkermes Plc (NASDAQ:ALKS) reported strong financial results for the fourth quarter of 2024, surpassing earnings per share (EPS) and revenue forecasts. The company's EPS stood at $1.05, significantly ...

Exact timing for the debut of the fourth-generation iPhone SE remains up in the air, with Bloomberg's Mark Gurman reporting in a tweet tonight that the device "should be announced by next week." ...

Alkermes has agreed a $950 million deal to acquire Rodin Therapeutics, a US biotech developing drugs for neurodegenerative diseases. Dublin-headquartered Alkermes is paying $100 million upfront to ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Mark Travers, Ph.D., is an American psychologist who writes about psycho-educational topics such as happiness, relationships, personality, and life meaning. He holds degrees from Cornell ...

Which begs the question, what would have happened if Mark Cuban was still Mavericks majority owner? Mark Cuban sold off his majority share in the Mavericks and is now a minority owner. He no ...